JPM vs TCPC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
TCPC exhibits severe financial deterioration, highlighted by a weak Piotroski F-Score of 2/9 and a bearish technical trend of 0/100. While the stock trades at a significant discount to book value (P/B 0.61), this appears to be a value trap given the collapsing revenue (-28.30%) and EPS (-30.0%). Most critically, the 21.20% dividend yield is unsustainable, evidenced by a payout ratio of 377.78%, indicating the company is returning capital it is not earning. The combination of negative ROE and declining growth suggests a fundamental breakdown in the business model.
Compare Another Pair
Related Comparisons
JPM vs TCPC: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and BlackRock TCP Capital Corp. (TCPC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.